Our model also allowed us to make an estimate of the cost per QALY saved ($388) for the best treatment strategy (4 year TDF for mono-infections and 1 year PEG-IFN for co-infections), which was in line with previous estimates for universal TDF treatment [41]. The gene discussed is IFNA1; the disease is coinfection.